The application of genomic and molecular data in the treatment of chronic cancer pain

被引：24

作者：

Turabi, Ali ^{[1
]}

Plunkett, Anthony R. ^{[1
]}

机构：

[1] Walter Reed Army Med Ctr, Def & Vet Pain Management Initiat, Anesthesia & Operat Serv, Washington, DC 20307 USA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2012年 / 105卷 / 05期

关键词：

cancer pain; translational medicine; gene therapy; METHYLTRANSFERASE COMT GENE; NECROSIS-FACTOR-ALPHA; SUBSTANCE P-SAPORIN; DOUBLE-BLIND; INTRATHECAL ZICONOTIDE; NEUROPATHIC PAIN; DORSAL-HORN; OSTEOPROTEGERIN LIGAND; MORPHINE REQUIREMENTS; HEAT HYPERALGESIA;

D O I：

10.1002/jso.21707

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Many cancer patients will develop complex pain syndromes requiring aggressive, innovative, and comprehensive multimodal pain management strategies. Recently, data from both animal studies and clinical trials have allowed clinical research to focus on creating applicable clinical treatment strategies. This article is a review of genomic and molecular data, which has contributed to creating novel modalities for use in clinical pain management of patients with cancer-induced pain. J. Surg. Oncol. 2012; 105:494501. (c) 2012 Wiley Periodicals, Inc.

引用

页码：494 / 501

页数：8

共 101 条

[61]

Payne R, 1996, CANC NERVOUS SYSTEM

[62] Clinical implications of circulating angiogenic factors in cancer patients [J].

Poon, RTP ;

Fan, ST ;

Wong, J .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :1207-1225

[63] Endothelin-A Receptor Antagonism Attenuates Carcinoma-Induced Pain Through Opioids in Mice [J].

Quang, Phuong N. ;

Schmidt, Brian L. .

JOURNAL OF PAIN, 2010, 11 (07) :663-671

[64]

Radinsky R, 1991, Semin Cancer Biol, V2, P169

[65] Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain [J].

Rakvag, Trude T. ;

Ross, Joy R. ;

Sato, Hiroe ;

Skorpen, Frank ;

Kaasa, Stein ;

Klepstad, Pal .

MOLECULAR PAIN, 2008, 4

[66] The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients [J].

Rakvåg, TT ;

Klepstad, P ;

Baar, C ;

Kvam, TM ;

Dale, O ;

Kaasa, S ;

Krokan, HE ;

Skorpen, F .

PAIN, 2005, 116 (1-2) :73-78

[67] A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain [J].

Rauck, Richard L. ;

Wallace, Mark S. ;

Leong, Michael S. ;

MineHart, Michael ;

Webster, Lynn R. ;

Charapata, Steven G. ;

Abraham, Jacob E. ;

Buffington, Daniel E. ;

Ellis, David ;

Kartzinel, Ronald .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2006, 31 (05) :393-406

[68] Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain:: OPRM1 and COMT gene [J].

Reyes-Gibby, Cielito C. ;

Shete, Sanjay ;

Rakvag, Trude ;

Bhat, Samrat V. ;

Skorpen, Frank ;

Bruera, Eduardo ;

Kaasa, Stein ;

Klepstad, Pål .

PAIN, 2007, 130 (1-2) :25-30

[69]

Roman C, 2001, MICROSC RES TECHNIQ, V52, P450, DOI 10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO

[70]

2-O

← 2 3 4 5 6 7 8 9 10 11 →